Jefferies Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $869K | Buy |
15,524
+1,121
| +8% | +$62.7K | 0.01% | 510 |
|
|
2022
Q2 | $745K | Sell |
14,403
-22,843
| -61% | -$1.18M | 0.01% | 506 |
|
|
2022
Q1 | $2.71M | Buy |
37,246
+23,624
| +173% | +$1.72M | 0.02% | 308 |
|
|
2021
Q4 | $1.61M | Buy |
13,622
+681
| +5% | +$80.5K | 0.01% | 481 |
|
|
2021
Q3 | $1.74M | Buy |
+12,941
| New | +$1.74M | 0.01% | 432 |
|
|
2021
Q2 | – | Sell |
-19,753
| Closed | -$1.59M | – | 1261 |
|
|
2021
Q1 | $1.59M | Buy |
19,753
+8,753
| +80% | +$702K | 0.01% | 441 |
|
|
2020
Q4 | $598K | Buy |
+11,000
| New | +$598K | ﹤0.01% | 620 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 973 |
|
|
2020
Q1 | – | Sell |
-49,175
| Closed | -$721K | – | 1489 |
|
|
2019
Q4 | $721K | Buy |
+49,175
| New | +$721K | 0.01% | 890 |
|